Auwaerter Paul Gisbert bought CAPR
January 2, 2024 · Form 4 insider transaction
Auwaerter Paul Gisbert bought 890 shares of Capricor Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
890
Price
$0.00
Total value
N/A
InsiderAuwaerter Paul Gisbert
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after890
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service.